C6 NBD Galactosylceramide (d18:1/6:0) (Synonyms: N-hexanoylNBD-Galactosylceramide, C6 NBD Galactosylceramide, NBD Galactosylceramide (d18:1/6:0), C6-NBD-GalCer, NBD GalCer(d18:1/6:0)) |
| Catalog No.GC43098 |
La galactosilceramida C6 NBD es un derivado activo de la galactosilceramida que estÁ marcado con nitrobenzoxadiazol C6 fluorescente (C6 NBD).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 170212-26-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
C6 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C6 nitrobenzoxadiazole group. C6 NBD galactosylceramide has been used to study intracellular localization and metabolism of galactosylceramide, a sphingolipid whose synthesis is disrupted in Krabbe disease due to a deficiency of galactosylceramide β-galactosidase.
Average Rating: 5 (Based on Reviews and 2 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *